VentriPoint Diagnostics (TSE:VPT) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Ventripoint Diagnostics Ltd. has successfully completed the first portion of its non-brokered private placement, raising $300,000 through unsecured convertible debentures, which insiders also invested in. These debentures come with a 10% annual interest rate, convertible into common shares at predetermined prices, and include automatic conversion features under certain conditions along with warrant incentives.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.